Akari Therapeutics, Plc (AKTX)
NASDAQ: AKTX · Real-Time Price · USD
1.270
-0.030 (-2.31%)
At close: Mar 28, 2025, 4:00 PM
1.250
-0.020 (-1.57%)
After-hours: Mar 28, 2025, 4:04 PM EDT
Akari Therapeutics, Market Cap
Akari Therapeutics, has a market cap or net worth of $31.44 million as of March 28, 2025. Its market cap has increased by 121.48% in one year.
Market Cap
31.44M
Enterprise Value
30.20M
1-Year Change
121.48%
Ranking
Category
Stock Price
$1.27
Market Cap Chart
Since September 28, 2015, Akari Therapeutics,'s market cap has decreased from $291.48M to $31.44M, a decrease of -89.21%. That is a compound annual growth rate of -20.89%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.61B |
| UnitedHealth Group | 472.03B |
| Johnson & Johnson | 394.52B |
| AbbVie | 363.15B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 226.88B |
| Merck & Co. | 225.40B |